Topic
novo-nordisk
2 stories related to this topic, newest first.
cnbc.comscience21 days ago
Medicare to Cover Wegovy and Zepbound for Obesity Treatment at $50 Monthly Copay Starting July 1
The temporary GLP-1 Bridge program will run through December 2027. Taxpayers will cover most costs for millions of new patients.
news18.comfinance47 days ago
French Regulator Fines Novo Nordisk and Eli Lilly Over Weight Loss Drug Ads
France's medicines regulator imposed fines on Novo Nordisk and Eli Lilly for misleading advertisements related to their weight loss drugs. The penalties come amid launches of oral GLP-1 medications in the U.S., with Novo Nordisk's Wegovy pill gaining early traction. Company execu…